Literature DB >> 33947981

Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.

Panayotis Kaloyannidis1, Ahmed Ayyad2, Zakaria Bahaliwah2, Belal Blowi2, Wael Alanazi2, Zahra Al Shammasi2, Hamdi Elsoudi3, Ibrahim Ibrahim3, Hani Al Hashmi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33947981     DOI： 10.1038/s41409-021-01318-6

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  1 in total

Review 1.  Infectious complications and vaccines.

Authors:  Per Ljungman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.